Hap Trading, LLC Concert Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $102,424 - $137,824	-23,600 Reduced 35.44%	43,000 $17,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $111,446 - $187,920	26,100 Added 64.44%	66,600 $88,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $66,360 - $150,732	23,700 Added 141.07%	40,500 $22,000
Q1 2022 May 12, 2022	SELL	$2.73 - $3.94 $9,555 - $13,790	-3,500 Reduced 17.24%	16,800 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $54,607 - $85,666	20,300 New	20,300 $10,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.